Elutia Inc. to acquire SimpliDerm business from Cellution

Elutia Inc. entered into an execution version of an asset purchase agreement with Cellution Biologics Inc. for the sale of SimpliDerm, subject to various conditions. This is a strategic expansion transaction. M&A